Compounds > isocorydine
Page last updated: 2024-08-21

isocorydine and Liver Neoplasms

isocorydine has been researched along with Liver Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L; Chen, T; Cui, Y; Fang, T; Ge, C; Jiang, G; Li, H; Li, J; Li, M; Liu, J; Tian, H; Xie, H; Yao, M; Zhang, L1
Chen, L; Ge, C; Li, H; Li, J; Li, M; Liu, J; Tian, H; Wang, T; Yao, M; Zhang, L; Zhao, F1
Ge, C; Hou, H; Li, J; Lu, P; Sun, H; Wang, T; Yao, M; Zhang, L; Zhao, F2

Other Studies

4 other study(ies) available for isocorydine and Liver Neoplasms

ArticleYear
An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma.
    Oncotarget, 2015, Sep-22, Volume: 6, Issue:28

    Topics: AC133 Antigen; Antibiotics, Antineoplastic; Antigens, CD; Antineoplastic Agents; Aporphines; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Female; Glycoproteins; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Niacinamide; Peptides; Phenylurea Compounds; Protein Kinase Inhibitors; RNA Interference; RNA-Binding Proteins; Sorafenib; Survival Analysis; Time Factors; Transfection

2015
Derivate isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/M cell cycle arrest and apoptosis.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Aporphines; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Protein-beta; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Female; G2 Phase Cell Cycle Checkpoints; Humans; Liver Neoplasms; Niacinamide; Nuclear Proteins; Phenylurea Compounds; Signal Transduction; Sorafenib; Tumor Burden; Xenograft Model Antitumor Assays

2016
Isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/m cell cycle arrest and apoptosis.
    PloS one, 2012, Volume: 7, Issue:5

    Topics: Apoptosis; Aporphines; Blotting, Western; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Checkpoint Kinase 2; Flow Cytometry; Humans; Liver Neoplasms; Papaveraceae; Phosphorylation; Phytotherapy; Plant Extracts; Protein Kinases; Protein Serine-Threonine Kinases; RNA Interference; Tetrazolium Salts; Thiazoles

2012
Isocorydine targets the drug-resistant cellular side population through PDCD4-related apoptosis in hepatocellular carcinoma.
    Molecular medicine (Cambridge, Mass.), 2012, Sep-25, Volume: 18

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Aporphines; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Male; Mice; Neoplasm Proteins; RNA-Binding Proteins; Side-Population Cells; Xenograft Model Antitumor Assays

2012